Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
XBiotech ( (XBIT) ) has issued an announcement.
XBiotech Inc. has announced the appointment of Dr. Thomas Kündig and Craig Rademaker to its Board of Directors as of June 24, 2025. Dr. Kündig, a leader in academic medicine with significant contributions to immunodermatology, will join the Compensation Committee, while Mr. Rademaker, with extensive experience in the financial industry, will join the Audit Committee. These appointments are expected to enhance the company’s strategic direction and governance, potentially impacting its operations and industry positioning positively.
More about XBiotech
Average Trading Volume: 55,333
Technical Sentiment Signal: Sell
Current Market Cap: $76.22M
See more data about XBIT stock on TipRanks’ Stock Analysis page.